Talphera Inc. (TLPH)

[mick]

$ACRX cash cow !!!!!
used to pay for 2nd Phase 3 trial, SUCCESSFUL outcome:
NOTE: AcelRx Pharmaceuticals Receives $65 Million from the
Partial Sale of Zalviso™ European Royalties
and Commercial Milestones to PDL BioPharma
REDWOOD CITY, Calif., Sept. 21, 2015

"This transaction provides AcelRx with significant capital in a non-dilutive manner.

It will increase our estimated cash at year end to over $100 million
and should provide sufficient capital to complete regulatory submissions for ARX-04 in the U.S. and Europe,

and to conduct limited additional work on Zalviso, if needed,
in preparation for re-submitting a New Drug Application to the
U.S. Food and Drug Administration."